Privia Health Group (NASDAQ:PRVA) Given Overweight Rating at Stephens

Stephens reaffirmed their overweight rating on shares of Privia Health Group (NASDAQ:PRVA) in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a $32.00 target price on the stock.

Several other equities research analysts have also commented on the company. Barclays upped their price target on Privia Health Group from $23.00 to $24.00 and gave the stock an “equal weight” rating in a research note on Tuesday, May 27th. JMP Securities upped their price target on Privia Health Group from $29.00 to $30.00 and gave the stock a “market outperform” rating in a research note on Friday, August 29th. Piper Sandler dropped their price target on Privia Health Group from $36.00 to $35.00 and set an “overweight” rating for the company in a research note on Monday, August 11th. Evercore ISI dropped their price target on Privia Health Group from $30.00 to $28.00 and set an “outperform” rating for the company in a research note on Wednesday, July 9th. Finally, Citigroup reiterated an “outperform” rating on shares of Privia Health Group in a research note on Friday, August 29th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $28.58.

Privia Health Group Price Performance

Shares of NASDAQ:PRVA opened at $23.34 on Wednesday. The firm has a market capitalization of $2.86 billion, a PE ratio of 212.20, a P/E/G ratio of 3.40 and a beta of 0.82. The business has a 50-day moving average of $21.39 and a two-hundred day moving average of $22.40. Privia Health Group has a 12 month low of $16.47 and a 12 month high of $26.09.

Privia Health Group (NASDAQ:PRVA) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.05 by ($0.03). The firm had revenue of $521.15 million for the quarter, compared to analyst estimates of $466.97 million. Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%.The business’s revenue was up 23.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.19 earnings per share. Privia Health Group has set its FY 2025 guidance at EPS. As a group, research analysts anticipate that Privia Health Group will post 0.14 earnings per share for the current year.

Institutional Investors Weigh In On Privia Health Group

A number of large investors have recently modified their holdings of PRVA. CWM LLC boosted its holdings in Privia Health Group by 50.3% in the first quarter. CWM LLC now owns 1,804 shares of the company’s stock valued at $40,000 after purchasing an additional 604 shares during the last quarter. Bessemer Group Inc. boosted its holdings in Privia Health Group by 2,393.4% in the first quarter. Bessemer Group Inc. now owns 2,269 shares of the company’s stock valued at $51,000 after purchasing an additional 2,178 shares during the last quarter. Russell Investments Group Ltd. boosted its holdings in Privia Health Group by 2,852.2% in the first quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company’s stock valued at $60,000 after purchasing an additional 2,567 shares during the last quarter. GAMMA Investing LLC boosted its holdings in Privia Health Group by 113.1% in the first quarter. GAMMA Investing LLC now owns 2,866 shares of the company’s stock valued at $64,000 after purchasing an additional 1,521 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd boosted its holdings in Privia Health Group by 2,115.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 3,323 shares of the company’s stock valued at $75,000 after purchasing an additional 3,173 shares during the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.